IDG Capital

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
4
Confirmed lead rounds
2
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$290M
1 disclosed · full round size, not this investor’s share

By stage

Series A2
Undisclosed2

By primary sector

AI2
Biotech1
Industrial tech1

By country

China4

Rounds

4 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Apex Intelligence

Apex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.

Lead
InfiMaker

Makes desktop five-axis CNC machines for engineers and small businesses

UndisclosedSeries A
Role not disclosed
Math Magic

AI platform generating 3D models and personalized physical products

UndisclosedSeries A+
Role not disclosed